<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01509248</url>
  </required_header>
  <id_info>
    <org_study_id>TP-PopPK-Metabol</org_study_id>
    <nct_id>NCT01509248</nct_id>
  </id_info>
  <brief_title>Population Pharmacokinetics and Metabolomics of Theophylline in Preterm Infants</brief_title>
  <official_title>Population Pharmacokinetics and Metabolomic Analysis of Aminopylline/Theophylline Drug Levels in Preterm Infants With Apnea of Prematurity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Boramae Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Population pharmacokinetics : The purpose of this study is&#xD;
&#xD;
           - to investigate the population pharmacokinetics of theophylline in premature Korean&#xD;
           infants and to assess the influence of demographic and clinical covariates.&#xD;
&#xD;
        2. Metabolomics : The purpose of this study are&#xD;
&#xD;
             -  to predict serum theophylline levels and to assess CYP1A2 activities in premature&#xD;
                infants by analyzing urinary metabolites of theophylline&#xD;
&#xD;
             -  to examine which factors affect clearance of theophylline and CYP1A2 activity in&#xD;
                premature infants&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>May 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Apea of Prematurity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Admitted to Neonatal Intensive Care Unit&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inborn preterm infants (GA &lt; 37 weeks)&#xD;
&#xD;
          -  Dx : Apnea of prematurity&#xD;
&#xD;
          -  Tx : Aminophylline / Theophylline&#xD;
&#xD;
          -  Informed consent of parents&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major congenital anomaly&#xD;
&#xD;
          -  Expired within 72 hours&#xD;
&#xD;
          -  Proven secondary apnea&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>37 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2012</verification_date>
  <study_first_submitted>January 9, 2012</study_first_submitted>
  <study_first_submitted_qc>January 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2012</study_first_posted>
  <last_update_submitted>February 21, 2012</last_update_submitted>
  <last_update_submitted_qc>February 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Han-Suk Kim</investigator_full_name>
    <investigator_title>Associate Professor &amp; Director of Neonatal Intensive Care Unit</investigator_title>
  </responsible_party>
  <keyword>Theophylline</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

